Similar articles

• Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

  Lilja H, Ulmert D, Vickers AJ. Lilja H, et al. Nat Rev Cancer. 2008 Apr;8(4):268-78. doi: 10.1038/nrc2351. Nat Rev Cancer. 2008. PMID: 18337732 Review.
• Prostate-specific antigen in clinical practice.

  Loeb S, Catalona WJ. Loeb S, et al. Cancer Lett. 2007 Apr 28;249(1):30-9. doi: 10.1016/j.canlet.2006.12.022. Epub 2007 Jan 26. Cancer Lett. 2007. PMID: 17258389 Review.
• [Prostatic specific antigen: role and significance in urologic practice].

  Manolović D, Pejcić T, Milović N. Manolović D, et al. Srp Arh Celok Lek. 1994 May-Jun;122(5-6):171-3. Srp Arh Celok Lek. 1994. PMID: 17977420 Review. Serbian.
• Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?

  Connolly D, Black A, Murray LJ, Nambirajan T, Keane PF, Gavin A. Connolly D, et al. Prostate Cancer Prostatic Dis. 2009;12(1):47-51. doi: 10.1038/pcan.2008.37. Epub 2008 Sep 2. Prostate Cancer Prostatic Dis. 2009. PMID: 18762815
• Prostate specific antigen (PSA)-based screening.

  Suzuki H, Flanigan RC, Okuyama A; American Urological Association. Suzuki H, et al. Int J Urol. 2008 Sep;15(9):757-62. doi: 10.1111/j.1442-2042.2008.02122.x. Int J Urol. 2008. PMID: 18786202 No abstract available.